Stephanie Minter
Internal Medicine · Bradenton, FLNPI 1043581523
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,277 and has fallen 88.7% since, to $145 in 2025.
Across 82 payments — averaging $27.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$452
- Organogenesis Inc.$317
- Novo Nordisk$225
- Smith+Nephew$207
- AbbVie$164
- Davol Inc.$138
- plus $731 from 21 others
What the payments were for
- Food & beverage$2,234100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $452 |
| Organogenesis Inc. | 6 | $317 |
| Novo Nordisk | 13 | $225 |
| Smith+Nephew | 9 | $207 |
| AbbVie | 9 | $164 |
| Davol Inc. | 1 | $138 |
| AstraZeneca | 3 | $127 |
| Lilly USA, LLC | 4 | $64 |
| Abiomed | 1 | $60 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $57 |
| Novartis | 3 | $43 |
| GSK | 2 | $38 |
| Si-bone, Inc. | 1 | $34 |
| Radius Health, Inc. | 2 | $30 |
| Pfizer | 2 | $29 |
| Merck | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Stryker | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$350
- Phasix Mesh$138
- Apligraf$108
- BREZTRI$104
How this compares
$2,234 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Other internal medicine in Bradenton
- Ian KahaneBradenton$126K
- Joseph PaceBradenton$69K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.